IVERIC bio, Inc. (ISEE)
After hours:
Chart Events
Performance Outlook
| Previous Close | 12.81 |
| Open | 13.00 |
| Bid | 13.25 x 3000 |
| Ask | 14.74 x 4000 |
| Day's Range | 12.81 - 13.37 |
| 52 Week Range | 8.37 - 19.34 |
| Volume | |
| Avg. Volume | 2,111,930 |
| Market Cap | 1.565B |
| Beta (5Y Monthly) | 1.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.08 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ISEE
Related Research
- IVERIC bio, Inc.Technical Assessment: Neutral in the Intermediate-TermCrude oil (WTI) continues to correct, pulling gasoline prices down with it. Since peaking at $123.68 on an intraday basis June 14, crude has been in a consistent downward-sloping channel. On Wednesday, WTI closed near $90.80/barrel, its lowest close since February18 and down 26% from its most-recent closing high of $122.11. More importantly, crude oil, at least for a day, has broken the bottom of its range (in the $93 region) going back to March. We need to see a few more days to confirm a major breakdown.RatingFair ValueEconomic Moat4 days agoArgus Research
- InvestorPlace
7 Cheap Biotech Stocks to Buy Now
Biopharmaceutical companies have been struggling since 2021 and that narrative isn’t immediately changing. However, not every firm deserves this fate. In fact, investors can find great opportunities with “cheap” biotech stocks to buy now. There are many reasons for investor pessimism that could soon ease. For instance, drug innovation has stagnated in 2022. Companies also haven’t been able to announce as many positive clinical readouts to build confidence. These both could change in a jiffy if a
- Business Wire
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
PARSIPPANY, N.J., August 03, 2022--Iveric Bio announced the Company will participate in a fireside chat at the Wedbush PacGrow Healthcare Conference 2022 on Tuesday, August 9, 2022.
- Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J., August 02, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive employees.
